Voice-activated and Touchscreen-controlled Smart Speaker Intervention for Older Adults With Poorly Controlled Type 2 Diabetes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorMedical College of Wisconsin

About this trial

This is a pre-post pilot study that will test the feasibility and acceptability of a health educator delivered diabetes education and skills training intervention using a voice-activated, touch screen controlled, smart speaker. We will enroll 30 adults aged 50 and older with poorly controlled type 2 diabetes as defined by a hemoglobin A1C of 8% in the study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1) Aged 50 and older; 2) clinical diagnosis of poorly controlled type 2 diabetes, defined as HbA1C greater than or equal to 8% at the screening visit; 3) willing to install and use the VATC-SS for the 3 months of the study.

Disqualifiers

1) Mental confusion at screening assessment suggesting significant dementia; 2) alcohol or drug abuse/dependency at screening assessment; 3) active psychosis or acute mental disorder at screening assessment.

Trial design

Design model

Single group

Treatments tested in this trial

  • VATC-SS Intervention

    Behavioral

    Individuals in the VATC-SS intervention will receive weekly diabetes education and skills training calls for 12 weeks from a health educator through the voice-activated, touch screen controlled smart speaker.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: VATC-SS InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

HemoglobinA1C

About 10cc of blood will be drawn by phlebotomist and sent to the lab for testing

Time frame
Baseline and 3-months post enrollment
2

Blood Pressure

Blood pressure readings will be obtained using automated blood pressure monitors (OMRON IntelliSenseTM HEM-907 XL). The device will be programmed to take 3 readings at 2-minute intervals and give an average of the 3 blood pressure readings.

Time frame
Baseline and 3-months post-enrollment
3

Low-Density Lipoprotein Cholesterol

About 10cc of blood will be drawn by phlebotomist and sent to the lab for testing

Time frame
Baseline and 3-months post-enrollment

Secondary outcomes

1

Depression

Depression will be measured using the 9-item Patient Health Questionnaire (PHQ-9)

Time frame
Baseline and 3-months post-enrollment
2

Social Isolation

The PROMIS Short Form v2.0 - Social Isolation 8a will be used to measure social isolation

Time frame
Baseline and 3-months post-enrollment
3

Loneliness

The five-item Loneliness Fixed form from the NIH Toolbox Item Bank v3.0 for adults will be used to assess loneliness

Time frame
Baseline and 3-months post-enrollment

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: